1. Home
  2. TRML vs RBB Comparison

TRML vs RBB Comparison

Compare TRML & RBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRML
  • RBB
  • Stock Information
  • Founded
  • TRML 2021
  • RBB 2008
  • Country
  • TRML United States
  • RBB United States
  • Employees
  • TRML N/A
  • RBB N/A
  • Industry
  • TRML Biotechnology: Pharmaceutical Preparations
  • RBB Major Banks
  • Sector
  • TRML Health Care
  • RBB Finance
  • Exchange
  • TRML Nasdaq
  • RBB Nasdaq
  • Market Cap
  • TRML 419.1M
  • RBB 415.0M
  • IPO Year
  • TRML N/A
  • RBB 2017
  • Fundamental
  • Price
  • TRML $27.66
  • RBB $24.05
  • Analyst Decision
  • TRML Strong Buy
  • RBB Hold
  • Analyst Count
  • TRML 3
  • RBB 5
  • Target Price
  • TRML $64.67
  • RBB $19.30
  • AVG Volume (30 Days)
  • TRML 202.3K
  • RBB 48.2K
  • Earning Date
  • TRML 11-07-2024
  • RBB 10-21-2024
  • Dividend Yield
  • TRML N/A
  • RBB 2.66%
  • EPS Growth
  • TRML N/A
  • RBB N/A
  • EPS
  • TRML N/A
  • RBB 1.87
  • Revenue
  • TRML N/A
  • RBB $115,630,000.00
  • Revenue This Year
  • TRML N/A
  • RBB N/A
  • Revenue Next Year
  • TRML N/A
  • RBB $6.92
  • P/E Ratio
  • TRML N/A
  • RBB $12.90
  • Revenue Growth
  • TRML N/A
  • RBB N/A
  • 52 Week Low
  • TRML $12.12
  • RBB $13.30
  • 52 Week High
  • TRML $48.31
  • RBB $25.09
  • Technical
  • Relative Strength Index (RSI)
  • TRML 58.78
  • RBB 58.80
  • Support Level
  • TRML $25.10
  • RBB $21.73
  • Resistance Level
  • TRML $28.35
  • RBB $25.09
  • Average True Range (ATR)
  • TRML 1.37
  • RBB 0.74
  • MACD
  • TRML -0.26
  • RBB 0.09
  • Stochastic Oscillator
  • TRML 57.98
  • RBB 69.05

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

About RBB RBB Bancorp

RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.

Share on Social Networks: